Membio Inc. Alternatives & Competitors
12 companies similar to Membio Inc. — Scalable single-use bioreactors.
Companies similar to Membio Inc.
PBS Biotech
Next Generation Single-Use Bioreactors
LumaCyte
Transforming the status quo through rapid label-free single cell analysis
Carroucell
Experts in industrial bioprocess optimization | Scalable microcarrier tech for advanced ce...
Rival Readout
Competing with Membio Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
AlphaBio, Inc.
Enabling Abundance In Medicine™
WuXi Advanced Therapies
An integrated cell and gene therapy Contract Testing, Development and Manufacturing Organi...
Sepragen Corporation
Innovators in Bioprocessing
Kolibri
Þróum það besta í fólki og fyrirtækjum.
Limula
Cell & Gene Therapy: Automated. Scalable. Accessible
LFB Biomanufacturing
Your CDMO partner for antibodies and recombinant proteins
About Membio Inc.
Membio Inc., founded in 2018, is at the forefront of revolutionizing the biotechnology and pharmaceutical industries. Headquartered in Canada, the company has the bold slogan: "Scalable single-use bioreactors," encapsulating its mission to transform the way cells are grown for medical purposes. The challenge Membio add...
Bioreactors, Biomanufacturing, Bioprocess, Cell Therapy, Gene Therapy, Cell Culture, Bioprocess Development, R&D, Single-use, Benchtop Bioreactor, Cell Growth, Scalable Manufacturing, Automated Bioreactors, Proprietary Design
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Membio Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Membio Inc. on 26 Jul 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 18 Aug 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.